Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for 60 Degrees Pharmaceuticals Inc. (SXTP : NSDQ)

• Company Description    60 Degrees Pharmaceuticals Inc. specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. 60 Degrees Pharmaceuticals Inc. is based in WASHINGTON. Number of Employees: 3

• Price / Volume Information    Yesterday's Closing Price: $1.40 Daily Weekly Monthly 20 Day Moving Average: 71,002 shares Shares Outstanding: 4.10 (millions) Market Capitalization: $5.75 (millions) Beta: 2.73 52 Week High: $12.45 52 Week Low: $1.22 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 6.87% 4.99% 12 Week -35.18% -41.13% Year To Date -78.29% -80.34%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1025 CONNECTICUT AVENUE NW SUITE 1000 - WASHINGTON D.C.,WA 20036 USA ph: 202-327-5422 fax: - ir@60degreespharma.com http://www.60degreespharma.com

• General Corporate Information    Officers Geoffrey Dow - Chief Executive Officer; President and Director Tyrone Miller - Chief Financial Officer Kristen Landon - Chief Commercial Officer Charles Allen - Director Cheryl Xu - Director Peer Information 60 Degrees Pharmaceuticals Inc. (GSAC) 60 Degrees Pharmaceuticals Inc. (CASI) 60 Degrees Pharmaceuticals Inc. (ALCD.) 60 Degrees Pharmaceuticals Inc. (OMNN) 60 Degrees Pharmaceuticals Inc. (CGPI.) 60 Degrees Pharmaceuticals Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 83006G401 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/13/25 Share - Related Items Shares Outstanding: 4.10 Most Recent Split Date: 2.00 (0.20:1) Beta: 2.73 Market Capitalization: $5.75 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.21 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-4.92 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 7.19 EPS Growth vs. Year Ago Period: 94.09% vs. Previous Quarter: 19.87% Sales Growth vs. Year Ago Period: 755.56% vs. Previous Quarter: 68.31% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - -133.88 03/31/25 - -174.90 12/31/24 - -122.89 Current Ratio 06/30/25 - 2.27 03/31/25 - 3.14 12/31/24 - 3.25 Quick Ratio 06/30/25 - 1.80 03/31/25 - 2.71 12/31/24 - 2.98 Operating Margin 06/30/25 - -977.86 03/31/25 - -1,949.01 12/31/24 - -1,871.81 Net Margin 06/30/25 - -976.86 03/31/25 - -1,947.30 12/31/24 - -1,869.22 Pre-Tax Margin 06/30/25 - -978.74 03/31/25 - -1,947.30 12/31/24 - -1,168.14 Book Value 06/30/25 - -4.90 03/31/25 - -3.76 12/31/24 - -6.38 Inventory Turnover 06/30/25 - 0.57 03/31/25 - 0.75 12/31/24 - 0.88 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©